glp-1/gip agonist GLP1-GIP receptor co-agonists: a promising evolution in the treatment of type 2 diabetes | Acta Diabetologica Main physiological actions of the

This could be interpreted as alarming and signaling that we should lengthen NPO times, particularly in diabetic patients who may have undiagnosed gastroparesis, or it could potentially be seen as reassuring, indicating that maybe a low volume of gastric contents isnt as big of a risk factor for aspiration as once thought.1 The authors of this paper recommend that patients be fasted from solid food for 24 hours

doi: 10.3389/fphar.2024.1461398 [DOI] [PMC free article] [PubMed] [Google Scholar] 116.Makunts T, Joulfayan H, Abagyan R

Muscle is not cosmetic tissue

One final consideration is that as more states establish upper payment limit (UPL) setting authority either for prescription drug affordability boards or other similar entities, it becomes increasingly possible that GLP-1s could be subject to review and UPLs across various states

However, the answer may lie in the location and metabolic activity of the excessive adipose tissue in these patients